DEXCOM, INC. Acquisition Costs, Period Cost
DEXCOM, INC. (DXCM) reported Acquisition Costs, Period Cost of $300.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-02-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AcquisitionCosts · last filed 2014-02-20
- DEXCOM, INC. acquisition costs, period cost for the quarter ending 2012-12-31 was $0.00.
- DEXCOM, INC. acquisition costs, period cost for the quarter ending 2012-09-30 was $0.00.
- DEXCOM, INC. acquisition costs, period cost for the quarter ending 2012-06-30 was $100.00K.
- DEXCOM, INC. acquisition costs, period cost for fiscal 2012 was $300.00K.
| Period end | Acquisition Costs, Period Cost 3 month | Acquisition Costs, Period Cost 6 month | Acquisition Costs, Period Cost 9 month | Acquisition Costs, Period Cost 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $0.00 derived: sum of 2 quarters · filed 2014-02-20 | $100.00K derived: sum of 3 quarters · filed 2014-02-20 | $300.00K 10-K · filed 2014-02-20 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $100.00K derived: sum of 2 quarters · filed 2012-11-01 | $300.00K 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $100.00K 10-Q · filed 2012-08-06 | $300.00K 10-Q · filed 2012-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |